ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2450

Do Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis Have Reduced Fertility and Parity? a Systematic Review

Claire-Louise Murphy1, Harriet Sharp2, Hanh Nguyen3, Anisur Rahman1 and Ian Giles4, 1Rayne Institute, Centre for Rheumatology Research, UCL Division of Medicine, London, United Kingdom, 2Rheumatology, University College London, London, United Kingdom, 3Rheumatology, University College London Hospital, London, United Kingdom, 4Department of Rheumatology, University College London Hospital NHS Foundation Trust, London, United Kingdom

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Fertility, rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 15, 2016

Title: Reproductive Issues in Rheumatic Disorders - Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Systemic Lupus Erythematosus (SLE) and Rheumatoid Arthritis (RA) often affect women of reproductive age. It remains unclear as to whether these inflammatory rheumatic conditions have an impact on fertility and parity. The aim of our study was to perform a systematic review of the literature to determine if fertility and parity are affected in patients with SLE and RA.

Methods: MEDLINE and EMBASE databases were searched for relevant publications from their inception through to October 2015, using terms including SLE and RA combined with fertility and parity. PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines were followed. MeSH terms such as fertility (fertil*) and pregnancy (pregn*) were included. Two authors screened abstracts to identify eligible articles.

Results: 2,444 articles were identified which consisted of 1,724 and 720 articles from EMBASE and MEDLINE databases respectively. 1,840 duplicated articles were excluded. After exclusion of non-rheumatological conditions, 334 articles remained. 38 papers related to SLE and RA were identified of which 4 papers had both SLE and RA data totalling RA=22 and SLE n=20. A total of 7293 patients, 4406 with RA and 2287 with SLE were included. Articles captured retrospective and prospective case control, cohort and cross-sectional studies ranging from years 1956 to 2015. There was variation in SLE and RA diagnostic criteria used. Exclusion criteria such as other rheumatic diseases such as antiphospholipid syndrome, effects of fertility on disease, assisted reproduction, conference abstracts and non-English papers were applied. In the RA cohort, 5 studies reported no difference in fertility and/or parity. 8 RA studies reported reduced fertility/early menopause and 9 reduced parity/increased pregnancy loss. In the SLE cohort, 5 studies reported no difference in fertility and/or parity. 11 reported reduced fertility/ovarian reserve or menstrual dysfunction affecting fertility and 6 reported reduced parity/pregnancy loss.

Conclusion:  This comprehensive review captured fertility and parity information on 7,293 patients. Limitations of our analysis included heterogeneity of outcome measures, which included ovarian reserve, anti-mullerian hormone (AMH) levels, TTP (time to pregnancy), nulliparity, premature menopause and pregnancy rates. Additionally, potential confounding factors included the effect of disease activity and differences between older and more recent studies. Despite the limitations, the majority of studies showed reduction in fertility and/or parity. Data from multicentre cohorts would be valuable.


Disclosure: C. L. Murphy, None; H. Sharp, None; H. Nguyen, None; A. Rahman, None; I. Giles, None.

To cite this abstract in AMA style:

Murphy CL, Sharp H, Nguyen H, Rahman A, Giles I. Do Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis Have Reduced Fertility and Parity? a Systematic Review [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/do-patients-with-systemic-lupus-erythematosus-and-rheumatoid-arthritis-have-reduced-fertility-and-parity-a-systematic-review/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/do-patients-with-systemic-lupus-erythematosus-and-rheumatoid-arthritis-have-reduced-fertility-and-parity-a-systematic-review/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology